Crescent Capital BDC (CCAP)
Provides adviser-managed capital solutions to middle-market companies.
Crescent Capital BDC, Inc. (CCAP) Q2 2026 Earnings Call Transcript
Crescent Capital BDC, Inc. (CCAP) Q2 2026 Earnings Call Transcript
Crescent Capital BDC (CCAP) Misses Q2 Earnings and Revenue Estimates
Crescent Capital BDC (CCAP) came out with quarterly earnings of $0.36 per share, missing the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $0.46 per share a year ago.
July Income Rising - 1 Raise And 4 Business Development Company Cuts
WP Carey (WPC) delivered a steady dividend raise, maintaining a 5.1% yield and demonstrating resilient income performance. Four BDCs—PFLT, CCAP, CGBD, OBDC—implemented double-digit dividend cuts, reflecting sector volatility and recent price declines near 52-week lows. Despite dividend reductions, all BDCs remain in the RIG portfolio, with recommendations to hold as dividend coverage stabilizes and recovery potential emerges.
Crescent Capital BDC, Inc. Schedules Earnings Release and Conference Call to Discuss its Second Quarter Ended June 30, 2026 Financial Results
LOS ANGELES, July 24, 2026 (GLOBE NEWSWIRE) -- Crescent Capital BDC, Inc. ("Crescent BDC") (NASDAQ: CCAP) today announced it will release its financial results for the second quarter ended June 30, 2026 on Monday, August 10, 2026 after market close. Crescent BDC invites all interested persons to attend its webcast/conference call on Tuesday, August 11, 2026 at 12:00 p.
Crescent Capital: Why I Still Wouldn't Buy Even After The 19% Dividend Cut
Crescent Capital BDC, Inc. faces ongoing headwinds, with a 19% dividend cut following rising non-accruals and declining investment income. Despite a steep 39% discount to NAV and a 12%+ yield, I remain cautious given persistent inflation and the potential for further downside. CCAP's Q1 saw net investment income drop to $0.38/share and non-accruals spike to 5.7% at cost, pressuring NAV and dividend sustainability.
Crescent Capital: A Tactical 13% Yielding Case To Buy
Crescent Capital BDC, Inc. continues to underperform the index. Part of it is justified; part of it isn't. As of today, CCAP trades 40% below NAV and offers a yield of almost 13% that is underpinned by strong earnings coverage.
New Strong Sell Stocks for June 12th
CCAP, DAVA and RH have been added to the Zacks Rank #5 (Strong Sell) List on June 12, 2026.
Crescent Capital BDC, Inc. (CCAP) Q1 2026 Earnings Call Transcript
Crescent Capital BDC, Inc. (CCAP) Q1 2026 Earnings Call Transcript
Crescent Capital BDC (CCAP) Tops Q1 Earnings Estimates
Crescent Capital BDC (CCAP) came out with quarterly earnings of $0.42 per share, beating the Zacks Consensus Estimate of $0.41 per share. This compares to earnings of $0.45 per share a year ago.
Buy These 2 SBIC & Commercial Finance Stocks Despite Industry Weakness
Declining interest rates are likely to weigh on loan yields, while demand for personalized financing is expected to rise. The Zacks SBIC & Commercial Finance industry players like MAIN and CCAP are worth investing in.
Adams Asset Advisors LLC Raises Stock Holdings in Crescent Capital BDC, Inc. $CCAP
Adams Asset Advisors LLC raised its stake in shares of Crescent Capital BDC, Inc. (NASDAQ: CCAP) by 352.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 79,828 shares of the company's stock after acquiring an additional 62,189 shares
Crescent Capital BDC, Inc. (NASDAQ:CCAP) Receives Consensus Recommendation of “Moderate Buy” from Brokerages
Crescent Capital BDC, Inc. (NASDAQ: CCAP - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the six ratings firms that are currently covering the stock, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation, three have given a buy recommendation and one has given a strong buy
I'm Buying Up To 13% Yield For Future Retirement Income
Crescent Capital BDC and VICI Properties offer a barbell approach to income investing across interest rate cycles. CCAP provides a 13.1% yield, trades at a 33% discount to NAV, and maintains a conservative, first-lien, floating-rate loan portfolio. VICI delivers a 6.3% yield, robust AFFO growth, and long-term revenue stability via triple-net leases on premier gaming and experiential properties.
Crescent Capital BDC (CCAP) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
After losing some value lately, a hammer chart pattern has been formed for Crescent Capital BDC (CCAP), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Crescent Capital BDC (CCAP) Moves to Buy: Rationale Behind the Upgrade
Crescent Capital BDC (CCAP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Down 12% in 4 Weeks, Here's Why Crescent Capital BDC (CCAP) Looks Ripe for a Turnaround
Crescent Capital BDC (CCAP) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Crescent Capital BDC Q4 Earnings Call Highlights
Crescent Capital BDC (NASDAQ: CCAP) reported fourth-quarter net investment income (NII) of $0.45 per share, down slightly from $0.46 in the prior quarter, as lower reference rates weighed on interest income. Management said results again exceeded the quarterly dividend, and the board declared a regular quarterly cash dividend of $0.42 per share for the first quarter
Crescent Capital BDC, Inc. (CCAP) Q4 2025 Earnings Call Transcript
Crescent Capital BDC, Inc. (CCAP) Q4 2025 Earnings Call Transcript
Crescent Capital BDC, Inc. (NASDAQ:CCAP) Given Average Recommendation of “Moderate Buy” by Brokerages
Shares of Crescent Capital BDC, Inc. (NASDAQ: CCAP - Get Free Report) have earned an average rating of "Moderate Buy" from the six ratings firms that are currently covering the stock, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued
Cream Rises To The Top: 2 Top-Tier BDCs To Buy
Most BDC investors are value investors, who focus on income. The higher the multiple, the lower the yield - i.e., a mechanic that leads "bargain hunters" underemphasizing high P/NAV BDCs. In the article I detail why this kind of approach might be suboptimal.